-
Loading metrics
Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic Cells
- Octavian Bucur,
- Andreea Lucia Stancu,
- Ioana Goganau,
- Stefana Maria Petrescu,
- Bodvael Pennarun,
- Thierry Bertomeu,
- Rajan Dewar,
- Roya Khosravi-Far
x
- Published: October 14, 2013
- https://doi.org/10.1371/journal.pone.0077390